Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Department of Health and Human Services National Institutes of Health
Typ

Research/project funding

Posted on

Bewerbungsschluss

Reference Number

PAR-22-091

The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.
Categories: Education, Health.

More Information

Visit Website

Typ

Research/project funding

Posted on

Bewerbungsschluss

Reference Number

PAR-22-091

, USA